Touchlight Genetics Ltd is a biotechnology company operating in the field of DNA therapies and DNA technology. The Company develops an enzymatic means of DNA amplification that addresses all major limitations of plasmid DNA. Touchlight's in vitro dual enzyme process can amplify any circular template to commercial scale and quality. The Company's doggybone or dbDNA is a linear covalently closed, minimal DNA construct that contains no bacterial sequences. Touchlight's ambition is for dbDNA to underpin the development and commercialisation of the next generation of DNA products.
|Employees (est.) (Nov 2019)||37||(+13%)|
Time since last funding
|3 years ago|
Touchlight Genetics investors
|GBP||FY, 2008||FY, 2009||FY, 2010||FY, 2011||FY, 2012||FY, 2013||FY, 2014||FY, 2015||FY, 2016||FY, 2017||FY, 2018|
When was Touchlight Genetics founded?
Touchlight Genetics was founded in 2008.
Who are Touchlight Genetics key executives?
Touchlight Genetics's key executives are Jonny Ohlson, Neil Porter and Jill Makin.
How many employees does Touchlight Genetics have?
Touchlight Genetics has 37 employees.
Who are Touchlight Genetics competitors?
Competitors of Touchlight Genetics include Immusoft, Reneuron Group and GenSight Biologics.
Where is Touchlight Genetics headquarters?
Touchlight Genetics headquarters is located at Lower Sunbury Road, London.
Where are Touchlight Genetics offices?
Touchlight Genetics has offices in London and Hampton.
How many offices does Touchlight Genetics have?
Touchlight Genetics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies